We are Nanotransfer, co-founded by Cecilia Vasti, PhD, and Carla Giacomelli, PhD, researchers at the Institute of Physical Chemistry Research of Córdoba (INFIQC) CONICET-UNC and faculty members at the Faculty of Chemical Sciences of UNC. We are dedicated to facilitating and encouraging the development of gene therapies, aiming to positively impact people’s health. Our focus involves creating a ready-to-use, safe, and efficient delivery system for gene therapy applications.

Looking ahead to 2024, our goals include establishing collaboration agreements to advance ex vivo therapies for primary genetic immunodeficiencies.

Learn more